Create your account

Every account starts with 30 days of Researcher. Next you choose your plan and add a card; nothing is charged until day 30.

Your trial includes RS Universe, a 3D map of 31 million papers that shows how your field connects to others.

By continuing with Google or Apple you agree to the Terms and the Privacy policy.

NewRCTPeer reviewedOpen access

The Lancet · 2026

Key finding: Weekly semaglutide cut major cardiovascular events by 20% over 3.3 years versus placebo.

NewMeta-analysisPeer reviewedOpen access

Heart Rhythm · 2025

Key finding: Pooled across 11 cohorts, burden above 5.5 hours a day doubled ischaemic stroke risk.

NewCross-sectionalPreprintOpen access

medRxiv · 2026

Key finding: Performance fell from 0.91 to 0.78 AUROC at the two sites outside the training network.

Every new paper in your field, read by morning.

ReadSearch ranks each day’s new papers against your fields and sums up the ones worth your time.

Ranked daily digestNew papers from your fields, best first.
Key finding in one linePlain-language summaries you can check against the source.
Listen, translate, citeHear papers on the go, read them in your language, cite in one click.

Indexing papers from PubMed, arXiv, bioRxiv and medRxiv